High glucose downregulates endothelial progenitor cell number via SIRT1

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 6, 2008, Pages 936-945

  Balestrieri, Maria Luisa ^a   Rienzo, Monica ^b   Felice, Francesca ^a   Rossiello, Raffaele ^a   Grimaldi, Vincenzo ^b   Milone, Lara ^a   Casamassimi, Amelia ^b   Servillo, Luigi ^a   Farzati, Bartolomeo ^b   Giovane, Alfonso ^a   Napoli, Claudio ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b 1st School of Medicine   (Italy)

Author keywords

Endothelial progenitor cells; Glucose; SIRT1

Indexed keywords

GLUCOSE; HEAT SHOCK PROTEIN; LECTIN; MITOCHONDRIAL ENZYME; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHR; TRANSFERASE;

ANGIOGENESIS; ARTICLE; CALORIC RESTRICTION; CELL COUNT; CELL CYCLE; CELL METABOLISM; CONTROLLED STUDY; DEACETYLATION; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; STAINING; STEM CELL;

ACETYLATION; BLOTTING, WESTERN; CELL COUNT; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GLUCOSE; HELA CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUINS; STEM CELLS;

MAMMALIA;

EID: 43649087274     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.03.004     Document Type: Article

References (53)

1. Kaeberlein M., McVey M., and Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13 19 (1999) 2570-2580
2. Guarente L., and Picard F. Calorie restriction-the SIR2 connection. Cell 120 4 (2005) 473-482
3. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., Falcone S., Valesrio A., Cantoni O., Clementi E., Moncada S., and Carruba M.O. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310 5746 (2005) 314-317
4. Guarante L. Sirtuins as potential targets for metabolic syndrome. Nature 444 7121 (2006) 868-874
5. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M.W., and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 6993 (2004) 771-776
6. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., and Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 5666 (2004) 2011-2015
7. Bordone L., and Guarente L. Calorie restriction SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 6 4 (2005) 298-305
8. Ota H., Akishita M., Eto M., Iijima K., Kanei M., and Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell. Cardiol. 43 5 (2007) 571-579
9. Mattagajasingh I., Kim C.S., Naqvi A., Yamamori T., Hoffman T.A., Jung S.B., DeRicco J., Kasuno K., and Irani K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 104 37 (2007) 14855-14860
10. Potente M., Ghaeni L., Baldessari D., Mostoslavsky R., Rossig L., Dequiedt F., Haendeler J., Mione M., Dejana E., Alt F.W., Zeiher A.M., and Dimmeler S. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 21 20 (2007) 2644-2658
11. Abaci A., Oguzhan A., Kahraman S., Eryol N.K., Unal S., Arinc H., and Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99 17 (1999) 2239-2242
12. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications, Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288 20 (2002) 2579-2588
13. . Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., Menegolo M., Kreutzenberg d.S.V., Tiengo A., Agostini C., and Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45 9 (2005) 1449-1457
14. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., Verhaar M.C., Braam B., Rabelink T.J., and van Zonneveld A.J. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 1 (2004) 195-199
15. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., and Gurtner G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 22 (2002) 2781-2786
16. Ii M., Takenaka H., Asai J., Ibusuki K., Mizukami Y., Maruyama K., Yoon Y.S., Wecker A., Luedemann C., Eaton E., Silver M., Thorne T., and Losordo D.W. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res. 98 5 (2006) 697-704
17. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95 4 (2004) 343-353
18. Napoli C., Balestrieri A., and Ignarro L.J. Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. Curr. Pharm, Des. 13 31 (2007) 3245-3251
19. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 4 (1999) 434-438
20. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., and Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 7 (2003) 593-600
21. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kamper U., Dimmeler S., and Zeiher A.M. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 22 (2005) 2981-2987
22. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bohm M., and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 10 (2005) 999-1007
23. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 1 (2001) E1-E7
24. Kuki S., Imanishi T., Kobayashi K., Matsuo Y., Obana M., and Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ. J. 70 8 (2006) 1076-1081
25. Marchetti V., Menghini R., Rizza S., Vivanti A., Feccia T., Lauro D., Fukamizu A., Lauro R., and Federici M. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signalling. Diabetes 55 8 (2006) 2231-2237
26. Liguori A., Fiorito C., Balestrieri M.L., Crimi E., Bruzzese G., Williams-Ignarro S., D'Amora M., Sommese L., Grimaldi V., Minucci P.B., Giovane A., Farzati B., Ignarro L.J., and Napoli C. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur. J. Haematol. 80 (2008) 258-264
27. Ben-Shoshan J., and George J. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials. Pharmacol. Ther. 115 1 (2007) 25-36
28. Napoli C., Maione C., Schiano C., Fiorito C., and Ignarro L.J. Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. Trends Mol. Med. 13 7 (2007) 278-286
29. Casamassimi A., Balestrieri M.L., Fiorito C., Schiano C., Maione C., Rossiello R., Grimaldi V., Del Giudice V., Balestrieri C., Farzati B., Sica V., and Napoli C. Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture. J. Biochem. 141 4 (2007) 503-511
30. Lionetti V., Raiola A., Camardella L., Giovane A., Obel N., Pauly M., Favaron F., Cervone F., and Bellincampi D. Overexpression of pectin methylesterase inhibitors in Arabidopsis restricts fungal infection by Botrytis cinerea. Plant Physiol. 143 4 (2007) 1871-1880
31. Napoli C., de Nigris F., Welch J.S., Calara F.B., Stuart R.O., Glass C.K., and Palinski W. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 105 11 (2002) 1360-1367
32. Napoli C., de Nigris F., and Sica V. New advances in microarrays: finding the genes causally involved in disease. Methods Mol. Med. 108 (2005) 215-233
33. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 5 (2003) P3
34. Seeger F.H., Haendeler J., Walter D.H., Rochwalsky U., Reinhold J., Urbich C., Rossig L., Corbaz A., Chvatchko Y., Zeiher A.M., and Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 9 (2005) 1184-1191
35. Potente M., Urbich C., Sasaki K., Hofmann W.K., Heeschen C., Aicher A., Kollipara R., DePinho R.A., Zeiher A.M., and Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115 9 (2005) 2382-2392
36. Daitoku H., Hatta M., Matsuzaki H., Aratani S., Ohshima T., Miyagishi M., Nakajima T., and Fukamizu A. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. 101 27 (2004) 10042-10047
37. Chen Y.H., Lin S.J., Lin F.Y., Wu T.C., Tsao C.R., Huang P.H., Liu P.L., Chen Y.L., and Chen J.W. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 56 6 (2007) 1559-1568
38. Chua K.F., Mostoslavsky R., Lombard D.B., Pang W.W., Saito S., Franco S., Kaushal D., Cheng H.L., Fischer M.R., Stokes N., Murphy M.M., Appella E., and Alt F.W. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab. 2 1 (2005) 67-76
39. Lundberg A.S., Hahn W.C., Gupta P., and Weinberg R.A. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12 6 (2000) 705-709
40. Hopper R.K., Carroll S., Aponte A.M., Johnson D.T., French S., Shen R.F., Witzmann F.A., Harris R.A., and Balaban R.S. Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry 45 8 (2006) 2524-2536
41. Shantsila F., Watson T., and Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49 7 (2007) 741-752
42. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., Miche E., Bohm M., and Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109 2 (2004) 220-226
43. Balestrieri M.L., Schiano C., Felice F., Casamassimi A., Balestrieri A., Milone L., Servillo L., and Napoli C. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J. Biochem. 143 (2008) 179-186
44. Balestrieri M.L., Fiorito C., Crimi E., Felice F., Schiano C., Milone L., Casamassimi A., Giovane A., Grimaldi V., Del Giudice V., Minucci P.B., Mancini F.P., Servillo L., D'Armiento F.P., Farzati B., and Napoli C. Effect of red wine antioxidants and minor polyphenolic constituents on endothelial progenitor cells after physical training in mice. Int J. Cardiol. (Feb 4 2008) [Electronic publication ahead of print] PMID: 18255172.
45. de Nigris F., Balestrieri M.L., Ignarro S.-W., D'Armiento F.P., Lerman L.O., Byrns R., Crimi E., Palagiano A., Sica V., Ignarro L.J., and Napoli C. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J. Cardiov. Pharmacol. 50 4 (2007) 424-433
46. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., Miao L., Tothova Z., Corner J.W., Carrasco D.R., Jiang S., Gilliland D.G., Chin L., Wong W.H., Castrillon D.H., and DePinho R.A. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128 2 (2007) 309-323
47. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., and Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 4 (2004) 551-563
48. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 6865 (2001) 813-820
49. Dernbach E., Urbich C., Brandes R.P., Hofmann W.K., Zeiher A.M., and Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104 12 (2004) 3591-3597
50. Yang Y., Fu W., Chen J., Olashaw N., Zhang X., Nicosia S.V., Bhalla K., and Bai W. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9 11 (2007) 1253-1262
51. Kim E.J., Kho JH., Kang M.R., and Um S.J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 28 2 (2007) 277-290
52. Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D., Hay R.T., Gu W., and Pestell R.G. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. 280 11 (2005) 10264-10276
53. Callaghan M.J., Ceradini D.J., and Gurtner G.C. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid. Redox Signal. 7 11-12 (2005) 1476-1482